These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 9329065)

  • 21. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine expectancies influence the subjective and behavioral effects of caffeine.
    Harrell PT; Juliano LM
    Psychopharmacology (Berl); 2009 Dec; 207(2):335-42. PubMed ID: 19760283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the role of expectancy in caffeine withdrawal using the balanced placebo design.
    Juliano LM; Kardel PG; Harrell PT; Muench C; Edwards KC
    Hum Psychopharmacol; 2019 Mar; 34(2):e2692. PubMed ID: 30861208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions.
    Evans SM; Griffiths RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):285-94. PubMed ID: 10087016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine in sport. Urinary excretion of caffeine in healthy volunteers after intake of common caffeine-containing beverages.
    van der Merwe PJ; Müller FR; Müller FO
    S Afr Med J; 1988 Aug; 74(4):163-4. PubMed ID: 3406872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence.
    Heatherley SV; Hayward RC; Seers HE; Rogers PJ
    Psychopharmacology (Berl); 2005 Apr; 178(4):461-70. PubMed ID: 15696321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is caffeine a flavoring agent in cola soft drinks?
    Griffiths RR; Vernotica EM
    Arch Fam Med; 2000 Aug; 9(8):727-34. PubMed ID: 10927712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine withdrawal and high-intensity endurance cycling performance.
    Irwin C; Desbrow B; Ellis A; O'Keeffe B; Grant G; Leveritt M
    J Sports Sci; 2011 Mar; 29(5):509-15. PubMed ID: 21279864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2004 Apr; 75(4):259-73. PubMed ID: 15060505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of caffeine levels in retail beverages in Portugal.
    Pena A; Lino C; Silveira MI
    Food Addit Contam; 2005 Feb; 22(2):91-6. PubMed ID: 15823997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions.
    Tunnicliffe JM; Erdman KA; Reimer RA; Lun V; Shearer J
    Appl Physiol Nutr Metab; 2008 Dec; 33(6):1301-10. PubMed ID: 19088792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose caffeine physical dependence in humans.
    Griffiths RR; Evans SM; Heishman SJ; Preston KL; Sannerud CA; Wolf B; Woodson PP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1123-32. PubMed ID: 2262896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of placebo awareness on stimulant drug response in a double-blind trial.
    Nash JM; Holroyd KA; Rokicki LA; Kvaal S; Penzien DB
    Psychopharmacology (Berl); 2002 May; 161(3):213-21. PubMed ID: 12021824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misclassification of exposure: coffee as a surrogate for caffeine intake.
    Brown J; Kreiger N; Darlington GA; Sloan M
    Am J Epidemiol; 2001 Apr; 153(8):815-20. PubMed ID: 11296156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine content of prepackaged national-brand and private-label carbonated beverages.
    Chou KH; Bell LN
    J Food Sci; 2007 Aug; 72(6):C337-42. PubMed ID: 17995675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls.
    Louis ED; Jurewicz EC; Applegate L; Luchsinger JA; Factor-Litvak P; Parides M
    Mov Disord; 2004 May; 19(5):499-504. PubMed ID: 15133812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction.
    Rogers PJ; Heatherley SV; Hayward RC; Seers HE; Hill J; Kane M
    Psychopharmacology (Berl); 2005 Jun; 179(4):742-52. PubMed ID: 15887055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Caffeinated Coffee Consumption Does not Improve Time Trial Performance in an 800-m Run: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study.
    Marques AC; Jesus AA; Giglio BM; Marini AC; Lobo PCB; Mota JF; Pimentel GD
    Nutrients; 2018 May; 10(6):. PubMed ID: 29789507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of different protocols of caffeine intake on metabolism and endurance performance.
    Cox GR; Desbrow B; Montgomery PG; Anderson ME; Bruce CR; Macrides TA; Martin DT; Moquin A; Roberts A; Hawley JA; Burke LM
    J Appl Physiol (1985); 2002 Sep; 93(3):990-9. PubMed ID: 12183495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.